CASI
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 31 Mar 2025)
What this means for you
Registered since 14 May 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87892837
- Registration number
- 5748674
- Mark type
- Stylized text
- Filed
- 25 Apr 2018
- Published for opposition
- 26 Feb 2019
- Registered
- 14 May 2019
- Attorney of record
- Stacey J. Watson
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; development of pharmaceutical preparations and medicines; provision of scientific information via Internet portals in the field of medical research and biotechnology; Product development research and product development in the field of pharmaceutical, biological and biotechnological products; medical research and product development services in the field of treatments for cancer, cardiovascular, metabolic, inflammatory, nervous system, anti-infective, and dermatological conditions; pharmaceutical research and development of human therapeutics using gene editing; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Biochemical research and development; Biological research; Biomedical research services; Clinical research in the field of cancer; Conducting clinical trials for others in the field of cancer; Conducting early evaluations in the field of new pharmaceuticals; Genotyping services for research or analysis purposes; Laboratory research services relating to pharmaceuticals; Medical research; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research; Scientific research and development; Stem cell research; Technical research in the field of pharmaceutical studies
Owner
- CASI PHARMACEUTICALS, INC., Rockville, MD, US
- CASI PHARMACEUTICALS, INC., Rockville, MD, US
- CASI PHARMACEUTICALS, INC., Rockville, MD, US
Prosecution history
- 31 Mar 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Mar 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 31 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Dec 2024 — TEAS SECTION 8 & 15 RECEIVED
- 14 May 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 May 2019 — REGISTERED-PRINCIPAL REGISTER
- 26 Feb 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Feb 2019 — PUBLISHED FOR OPPOSITION
- 06 Feb 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Jan 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jan 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Jan 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Jan 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Aug 2018 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Aug 2018 — NON-FINAL ACTION E-MAILED